Description
A derivative of anisomycin; inhibits the growth of the P. falciparum strains K1 and T9-96 in vitro (IC50s = 40.29 and 33.57 μM, respectively); cytotoxic to LU99 lung carcinoma and MCF-7 breast cancer cells (IC50s = 23 and 34 μM, respectively); been used as a negative control for assessment of protein synthesis inhibitor activity in molluscan neurons
Formal name: (2R,3S,4S)-2-[(4-methoxyphenyl)methyl]-3,4-pyrrolidinediol
Synonyms: (−)-Deacetylanisomycin|SA 3097D1
Molecular weight: 223.3
CAS: 27958-06-1
Purity: ≥99%
Formulation: A solid
Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Research Area|Cancer|Cell Death||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Parasitic Diseases|Malaria